ICD-10-CM Billable Code

C81.9A

Hodgkin lymphoma, unspecified, in remission

Clinical Classification Guidelines

Medical Intelligence & Overview

Hodgkin lymphoma is a type of cancer that begins in the lymphatic system, which is part of the body’s immune system. When diagnosed, it often responds well to treatment. The code C81.9A refers to a specific situation where a person had Hodgkin lymphoma, but it is now in remission. Being in remission means that signs and symptoms of the disease are reduced or have disappeared following treatment, though careful monitoring continues. This condition requires ongoing medical attention to maintain health and detect any potential recurrence early.

Causes & Symptoms

Clinical Causes: Genetic factors: Family history can increase risk. Immune system deficiencies: Conditions that weaken the immune system may contribute. Previous radiation therapy: Exposure to radiation treatments in the chest or neck area has been associated with increased risk. Infections: Certain viral infections, such as Epstein-Barr virus, have a link to Hodgkin lymphoma. Environmental factors: Exposure to certain chemicals or toxins might play a role, although specific links are not well established.

Key Symptoms: Swollen lymph nodes: Painless swelling often in the neck, armpits, or groin. Fever: Persistent or recurring without an obvious cause. Night sweats: Excessive sweating during the night, drenching clothing or bedding. Unexplained weight loss: Losing weight without trying or changes in appetite. Fatigue: Feelings of persistent tiredness. Itching: Generalized itching over the body. Persistent cough or chest discomfort: Especially if the lymphoma involves the chest area. Abdominal pain or swelling: If the lymph nodes in the abdomen are affected.

Diagnostic & Treatment

Diagnosis Path: Diagnosis generally involves a combination of medical history, physical examination, and several diagnostic tests. These may include:

Treatment Protocols: While Hodgkin lymphoma in remission indicates an effective previous treatment response, ongoing care is essential to sustain remission and monitor for potential recurrence. Treatment strategies may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C81.9A a billable ICD-10 code?
Yes, C81.9A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C81.9A?
Clinical documentation must specify the nature of Hodgkin lymphoma, unspecified, in remission and any associated comorbidities for accurate reporting.

Cite this Clinical Reference